Polysubstance use means exposure to more than one substance. It can involve intentional combinations, different substances used at different times, or a product containing something the person did not know was present. When mental health symptoms are also involved, the care plan needs an accurate history and clear priorities. The most noticeable substance or diagnosis is not necessarily the concern requiring attention first.
Serious breathing difficulty, inability to wake normally, a seizure, collapse, severe confusion, chest pain, or immediate danger of self-harm requires emergency help. Tell responders about all known substances and medicines, including uncertainty about their contents. Do not try to counter one substance with another or wait to identify the exact cause before seeking care.
Replace a single label with a usable history
Start with what has been used recently, including alcohol, prescribed medicines, nonprescribed drugs, sleep products, and supplements. Record the approximate pattern, last known use, and recent changes. If amounts or product contents are uncertain, say so. A clinician can work with clearly stated uncertainty more safely than with a simplified account that sounds precise but omits important details.
The CDC explains that polysubstance exposure can happen without the person’s knowledge, including through counterfeit or mixed products. This is why a product’s appearance or the name under which it was obtained does not establish the full exposure. Tell the team what was believed to be in it and what information is actually known.
Distinguish prescribed instructions from actual use. A medicine taken intermittently, a prescription that ran out, and a medicine taken more often than directed each raise different questions. Bring labeled containers, pharmacy records, or a current list if available. Do not delay emergency care to construct a perfect history; the information can be completed as assessment proceeds.
Put the sequence on one page
Create a short timeline showing substance use, medication changes, sleep, and the onset of important symptoms. This can reveal questions that separate lists miss. Did anxiety appear before a substance was used, after it, or during an interruption? Did a period of little sleep precede a major mood or behavioral change? These details help clinicians decide what to investigate.
The timeline should support assessment, not serve as a self-diagnostic formula. Several factors may be involved at once, and memory may be incomplete. If a supporter provides observations, distinguish what they saw from what they infer. Our symptom timeline guide explains how to organize the information without creating false certainty.
Include earlier periods when the symptoms occurred outside the current substance pattern. A history of depression, psychosis, panic, or attention difficulties can be relevant even if the current episode follows use. Conversely, an old diagnosis should not prevent assessment of a new substance-related or medical problem. The team needs both the longer history and the recent sequence.
Clarify whether substances were used together in the same episode or at different times across the week. A person may use one substance to change the effects of another, or have separate routines with different triggers. Explain those links without trying to calculate which combination is safe. The clinician needs the pattern to assess current risk and to understand which situations the longer-term treatment must address.
Prioritize immediate risks before final labels
Ask the assessing clinician to explain what needs attention now and why. The priority may be an acute medical problem, psychiatric safety, withdrawal from a particular substance, or continuity of an essential medicine. These decisions should be based on the actual presentation. A plan organized only around the substance named in the referral may miss another urgent need.
If alcohol or benzodiazepine dependence may be present, disclose it before making abrupt changes. If an opioid-related concern is present, ask the clinician about appropriate treatment and overdose prevention. Do not apply the withdrawal expectations for one substance to another. Each part of the history may have different implications for setting, monitoring, and follow-up.
| Priority question | What the team should clarify |
|---|---|
| Is there an emergency? | The current medical or psychiatric response required. |
| Could interruption create risk? | Which substances or medicines need a clinician-directed plan. |
| What remains uncertain? | The working explanations and how they will be reassessed. |
| Who coordinates care? | The lead contact and responsibilities across services. |
Use screening to open questions, not close them
Screening tools can help clinicians identify areas needing further assessment. NIDA’s TAPS tool covers tobacco, alcohol, prescription medication, and other substances and explicitly distinguishes screening information from a confirmed diagnosis. A score should not be treated as the full explanation for symptoms or a complete treatment plan.
Ask what any screening result means in your case. Which concern requires further assessment, and what information would confirm or change the working view? A person can screen positively for a problem without meeting every diagnostic criterion, and a tool may not capture all relevant context. Honest answers and a clinical interview remain important.
The same principle applies to mental health questionnaires. Depression, anxiety, or attention scores need interpretation alongside substance use, medication, sleep, medical conditions, and history. If the clinician reaches a diagnosis, ask for the reasoning in plain language. Our screening and diagnosis guide explains this distinction in more detail.
Keep existing treatment visible
Do not assume that every prescribed medicine should be stopped because several substances are involved. Some medicines are treating conditions that remain important, and some require careful management if changed. Ask who will review the list, what the purpose of each medicine is, and how the current prescribers will be contacted with appropriate consent.
If different clinicians have issued conflicting instructions, ask for a coordinated review. The patient should not decide which advice to follow by trial and error. Record what has actually been taken and request a clear current plan. If a change is made, ask for the rationale, monitoring, and next review point so the next service can understand it.
NIMH’s co-occurring disorders guidance supports considering mental health and substance use together. In practice, that means preserving appropriate treatment while assessing risks, rather than allowing a single substance-related label to erase all other care. A complex history may require more coordination, but it should still lead to an understandable plan.
Choose a setting that can manage the combined needs
Ask the proposed service to review the actual assessment and explain its capabilities. Can it manage the current medical and psychiatric needs? Which clinicians are available, including outside normal hours? What requires referral or hospital transfer? A broad dual diagnosis claim does not show that every combination of needs can be managed at the advertised location.
If more than one setting is needed, clarify the sequence and the handoffs. A hospital may address an acute problem before another service provides ongoing treatment. An outpatient team may coordinate several specialists. The appropriate arrangement depends on the person, but no interval should be left with everyone assuming another service is responsible.
Ask what happens if the first service cannot accept the referral or if symptoms change before admission. Identify an alternative contact and a concrete next step. A complex case should not become a chain of unanswered referrals while the person remains unwell. Clinical acceptance and practical access both need confirmation.
Build one treatment plan with several explicit goals
The plan may include treatment for more than one substance use disorder, a mental health condition, physical health, and practical problems such as housing or transport. Ask which goals are immediate and which come next. Trying to address every issue at maximum intensity at once may be difficult to sustain; the priorities should be explained and reviewed.
For each goal, name the professional responsible and the intervention being offered. General support is useful but does not describe whether the plan includes medication, psychological treatment, a medical referral, or practical case management. The patient should understand how the parts relate and how progress will be assessed.
Our shared care plan guide offers a structure for that discussion. Include the urgent response route, current medicines, consent for communication, and the next review date. A plan becomes more useful when it can be carried between services without forcing the patient to retell every detail from the beginning.
Ask how the plan accounts for practical limits such as transport, housing, language, cost, or difficulty remembering appointments. Several referrals can create an unmanageable schedule if no one considers how they fit together. A coordinator or agreed lead clinician can help identify the first necessary actions and reduce conflicting demands while keeping the important follow-up visible.
Review change without oversimplifying it
At follow-up, discuss symptoms, substance use, treatment participation, and daily functioning together. A reduction in one substance may coincide with increased use of another, while improvement in mood may not resolve practical barriers. The team needs the whole pattern. Do not hide changes because they complicate an earlier explanation.
Ask what evidence would lead to a different diagnosis, setting, or treatment approach. Uncertainty can decrease over time, but support should not be withheld until every question is settled. A named clinician and a planned review allow the formulation to evolve while care continues. The aim is a safer, more workable plan that accounts for the person rather than a collection of disconnected labels.
Sources and further reading
Found a detail that has changed? Tell the editorial team.